$1.67
1.2%
Downside
Day's Volatility :4.62%
Upside
3.47%
5.39%
Downside
52 Weeks Volatility :77.39%
Upside
76.11%
Period | Bon Natural Life Ltd | Index (Russel 2000) |
---|---|---|
3 Months | -13.92% | 0.0% |
6 Months | -62.83% | 0.0% |
1 Year | -72.4% | 0.0% |
3 Years | -98.43% | -22.3% |
Market Capitalization | 6.6M |
Book Value | $30.23 |
Earnings Per Share (EPS) | 5.0 |
PE Ratio | 0.33 |
Wall Street Target Price | 77.5 |
Profit Margin | 15.57% |
Operating Margin TTM | 19.08% |
Return On Assets TTM | 8.83% |
Return On Equity TTM | 13.78% |
Revenue TTM | 29.5M |
Revenue Per Share TTM | 32.3 |
Quarterly Revenue Growth YOY | -5.2% |
Gross Profit TTM | 9.4M |
EBITDA | 6.9M |
Diluted Eps TTM | 5.0 |
Quarterly Earnings Growth YOY | -0.41 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 4540.72%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 10.8M | - |
Net Income | 223.4K | - |
Net Profit Margin | 2.07% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 16.4M | ↑ 52.07% |
Net Income | 2.6M | ↑ 1052.23% |
Net Profit Margin | 15.7% | ↑ 13.63% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 18.2M | ↑ 11.12% |
Net Income | 3.0M | ↑ 17.6% |
Net Profit Margin | 16.61% | ↑ 0.91% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 25.5M | ↑ 39.93% |
Net Income | 4.6M | ↑ 51.68% |
Net Profit Margin | 18.01% | ↑ 1.4% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 29.9M | ↑ 17.31% |
Net Income | 6.2M | ↑ 35.87% |
Net Profit Margin | 20.86% | ↑ 2.85% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 29.5M | ↓ 1.29% |
Net Income | 4.6M | ↓ 26.32% |
Net Profit Margin | 15.57% | ↓ 5.29% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 8.1M | - |
Net Income | 1.8M | - |
Net Profit Margin | 22.74% | - |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 7.1M | - |
Net Income | 1.1M | - |
Net Profit Margin | 14.98% | - |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 14.1M | ↑ 100.0% |
Net Income | 2.1M | ↑ 100.0% |
Net Profit Margin | 14.98% | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 15.4M | ↑ 8.64% |
Net Income | 2.5M | ↑ 16.82% |
Net Profit Margin | 16.11% | ↑ 1.13% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 16.6M | - |
Total Liabilities | 12.1M | - |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 19.6M | ↑ 17.52% |
Total Liabilities | 12.3M | ↑ 1.64% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 25.2M | ↑ 28.84% |
Total Liabilities | 14.2M | ↑ 15.31% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 36.4M | ↑ 44.48% |
Total Liabilities | 9.9M | ↓ 30.33% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 37.3M | ↑ 2.32% |
Total Liabilities | 7.2M | ↓ 27.47% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 46.6M | ↑ 24.96% |
Total Liabilities | 10.6M | ↑ 47.6% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 37.3M | ↓ 5.39% |
Total Liabilities | 7.2M | ↓ 26.45% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 37.3M | ↑ 0.0% |
Total Liabilities | 7.2M | ↑ 0.0% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 47.2M | ↑ 26.71% |
Total Liabilities | 11.7M | ↑ 63.38% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 47.2M | ↑ 0.0% |
Total Liabilities | 11.7M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 46.6M | ↓ 1.38% |
Total Liabilities | 10.6M | ↓ 9.66% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 46.6M | ↑ 0.0% |
Total Liabilities | 10.6M | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 273.9K | - |
Investing Cash Flow | -1.7M | - |
Financing Cash Flow | 2.0M | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 7.1M | ↑ 2493.98% |
Investing Cash Flow | -8.4M | ↑ 400.41% |
Financing Cash Flow | 804.7K | ↓ 60.12% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.6M | ↓ 62.8% |
Investing Cash Flow | -3.0M | ↓ 64.38% |
Financing Cash Flow | 112.5K | ↓ 86.02% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 4.1M | ↑ 53.35% |
Investing Cash Flow | -7.4M | ↑ 147.87% |
Financing Cash Flow | 5.4M | ↑ 4658.28% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -187.1K | ↓ 104.62% |
Investing Cash Flow | -3.1M | ↓ 58.95% |
Financing Cash Flow | 2.3M | ↓ 57.75% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -65.3K | ↑ 0.0% |
Investing Cash Flow | -995.8K | ↑ 0.0% |
Financing Cash Flow | 912.2K | ↑ 0.0% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -28.3K | ↓ 56.7% |
Investing Cash Flow | -532.0K | ↓ 46.57% |
Financing Cash Flow | 218.5K | ↓ 76.04% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -28.3K | ↑ 0.0% |
Investing Cash Flow | -532.0K | ↑ 0.0% |
Financing Cash Flow | 218.5K | ↑ 0.0% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.1M | ↑ 3751.85% |
Investing Cash Flow | -9.1K | ↓ 98.3% |
Financing Cash Flow | 957.5K | ↑ 338.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.2M | ↑ 100.0% |
Investing Cash Flow | -9.1K | ↑ 0.0% |
Financing Cash Flow | 1.9M | ↑ 100.0% |
Sell
Neutral
Buy
Bon Natural Life Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Bon Natural Life Ltd | -14.88% | -62.83% | -72.4% | -98.43% | -97.68% |
![]() Air Products & Chemicals Inc. | -3.15% | 9.6% | -8.01% | 0.6% | 24.2% |
![]() Linde Plc | 3.39% | -1.81% | 18.17% | 44.74% | 146.67% |
![]() Dupont De Nemours Inc | 2.49% | 11.17% | 4.74% | 10.81% | 12.24% |
![]() Sherwin-williams Company, The | 6.22% | 4.69% | 33.07% | 19.15% | 106.97% |
![]() Ecolab Inc. | 5.83% | 9.12% | 34.88% | 7.89% | 22.05% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Bon Natural Life Ltd | 0.33 | 0.33 | NA | 0.0 | 0.14 | 0.09 | NA | 30.23 |
![]() Air Products & Chemicals Inc. | 23.76 | 23.76 | 1.46 | 12.34 | 0.16 | 0.05 | 0.03 | 67.93 |
![]() Linde Plc | 34.85 | 34.85 | 2.57 | 15.53 | 0.16 | 0.07 | 0.01 | 79.96 |
![]() Dupont De Nemours Inc | 104.13 | 104.13 | 0.45 | 3.77 | 0.01 | 0.03 | 0.02 | 55.9 |
![]() Sherwin-williams Company, The | 36.63 | 36.63 | 3.99 | 11.49 | 0.68 | 0.1 | 0.01 | 14.95 |
![]() Ecolab Inc. | 41.32 | 41.32 | 2.38 | 6.62 | 0.22 | 0.07 | 0.01 | 23.46 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Bon Natural Life Ltd | NA | $6.6M | -97.68% | 0.33 | 15.57% |
![]() Air Products & Chemicals Inc. | Buy | $60.8B | 24.2% | 23.76 | 21.24% |
![]() Linde Plc | Buy | $222.3B | 146.67% | 34.85 | 19.49% |
![]() Dupont De Nemours Inc | Buy | $34.0B | 12.24% | 104.13 | 5.51% |
![]() Sherwin-williams Company, The | Buy | $91.0B | 106.97% | 36.63 | 10.92% |
![]() Ecolab Inc. | Hold | $70.2B | 22.05% | 41.32 | 10.95% |
Insights on Bon Natural Life Ltd
In the last 1 year, Ecolab Inc. has given 34.9% return, outperforming this stock by 107.3%
In the last 3 years, Linde Plc has given 7.9% return, outperforming this stock by 106.3%
bon natural life was founded in 2006, is engaged in the research and development, production, and sales of plant extracts in china. dedicated to functional food, personal care and other fields to provide plant active ingredients and compound product solutions.<br> the company is headquartered in xi'an high-tech zone, shaanxi province, china with independent research and development center and testing laboratory, with two production bases in weinan and tongchuan, a new production base in yumen, gansu province under construction, marketing network coverage at home and abroad.bon has obtained production and operation license, iso9001 quality management system certification, iso22000 food safety management system certification, fda inspection certification, kosher, halal and other certifications. in the field of plant extracts, the production and sales of bon meet the relevant national standards and requirements.<br> as a high-tech enterprise driven by technology, bon has applied for
Organization | Bon Natural Life Ltd |
Employees | 96 |
CEO | Mr. Yongwei Hu |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$1.67
-3.46%
Keyarch Acquisition Corp
$1.67
-3.46%
Connexa Sports Technologies Inc
$1.67
-3.46%
Us Value Etf
$1.67
-3.46%
First Wave Biopharma Inc
$1.67
-3.46%
Global X Msci Next Emerging
$1.67
-3.46%
Fat Projects Acquisition Corp
$1.67
-3.46%
Capital Link Global Fintech
$1.67
-3.46%
Applied Uv Inc
$1.67
-3.46%